Novel Agent Safe in ALS, Phase II Study Suggests

(MedPage Today) -- Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily dose of the drug outperformed placebo for the primary outcome in a phase II trial in China.
At 180 days...